RECRUITING

Garmin PACT (Physical Activity Tracking in Type 1 Diabetes Using Garmin Vivosmart)

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational study is to test the Garmin Vivosmart in children and youth (8-21) with Type 1 Diabetes (T1D) and their parents. The main questions it aims to answer are: * Does the Garmin Vivosmart increase physical activity (PA)? * Does the Garmin Vivosmart improve T1D status Participants will: * Wear the Garmin Vivosmart (4 or higher) for a year * Complete surveys at the beginning, middle and end of participation asking about your T1D, T1D management, and PA * Parents of children will also complete similar surveys about T1D

Official Title

Garmin PACT (Physical Activity Tracking)

Quick Facts

Study Start:2024-01-16
Study Completion:2025-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05992350

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants aged 8-21 years of age and/or parent of participant aged 8-17 years of age
  2. * Participants diagnosed with T1D greater than 6 months ago
  3. * Participants must be patients at the Children's Mercy Kansas City network
  1. * Participants who do not meet age criteria above
  2. * Participants who do not have T1D
  3. * Participants who are unwilling to wear the device for at least 6 months

Contacts and Locations

Study Contact

Priscilla Connell, MPH
CONTACT
816-601-4543
pcconnell@cmh.edu
Emily DeWit
CONTACT
913 5155173
eldewit@cmh.edu

Principal Investigator

Mark Clements, MD
PRINCIPAL_INVESTIGATOR
Children's Mercy

Study Locations (Sites)

Children's Mercy
Kansas City, Missouri, 64111
United States

Collaborators and Investigators

Sponsor: Children's Mercy Hospital Kansas City

  • Mark Clements, MD, PRINCIPAL_INVESTIGATOR, Children's Mercy

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-16
Study Completion Date2025-11

Study Record Updates

Study Start Date2024-01-16
Study Completion Date2025-11

Terms related to this study

Additional Relevant MeSH Terms

  • Type 1 Diabetes